| connective tissue disease |
478 |
| mixed connective tissue disease |
478 |
| pneumatosis intestinalis |
478 |
| pneumoperitoneum |
478 |
| autoimmune disease |
498 |
| cathepsin g |
498 |
| immune reaction |
498 |
| inflammation |
498 |
| children |
395 |
| henoch-schönlein purpura |
395 |
| organ/system involvement |
395 |
| risk factors |
395 |
| interstitial lung disease |
431 |
| malignancy |
431, 482 |
| rheumatoid arthritis |
431 |
| tumor-associated antigen |
431 |
| edema |
482 |
| polymyositis |
482 |
| bone morphogenetic protein 6 |
424 |
| haplotype |
424 |
| polymorphism |
424 |
| systematic lupus erythematosus |
424 |
| cetylated fatty acid |
438 |
| cutaneous drug administration |
438 |
| knee osteoarthritis |
438 |
| exercise |
464 |
| hand osteoarthritis |
464 |
| nerve block |
464 |
| superficial branch of the radial nerve |
464 |
| ultrasound |
464, 418 |
| arab |
455 |
| ethnicity |
455 |
| lupus |
455 |
| middle east |
455 |
| systemic lupus erythematosus |
455 |
| arthritis |
389 |
| interleukin-6 |
389 |
| interleukin-33 |
389 |
| rheumatoid |
389 |
| tocilizumab |
389 |
| human immunodeficiency virus |
402 |
| prevalence |
402 |
| rheumatoid factor |
402 |
| viral hepatitis |
402 |
| ankylosing spondylitis |
408, 443 |
| short form of the social role participation questionnaire |
408 |
| social role participation |
408 |
| turkish version |
408 |
| validity and reliability |
408 |
| myofascial pain syndrome |
418 |
| trigger point |
418 |
| easi-qol |
443 |
| quality of life |
443 |
| colchicine |
473 |
| infantile colitis |
473 |
| perianal fistula |
473 |
